QFP
AUTL

Quantum Financial Partners’s Autolus Therapeutics AUTL Stock Holding History

Quantum Financial Partners’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.1K Buy
+18,795
New +$29.5K 0.02% 153

Other funds holding AUTL

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
BAM
Byrne Asset Management Kingston, New Jersey $185M AUM 41.05% 1-Year Est. Return

Quantum Financial Partners's AUTL Position: Q2 2026 in Review

Quantum Financial Partners opened a new position in Autolus Therapeutics (AUTL) in Q2 2026: 18,795 shares worth $30.1K. The stake represents 0.02% of the portfolio and ranks #153 among its holdings.

6 funds tracked by Wall St. Rank hold AUTL as of Q2 2026.

  • Quantum Financial Partners held 18,795 shares of Autolus Therapeutics worth $30.1K as of Q2 2026.
  • Autolus Therapeutics was a new Quantum Financial Partners position in Q2 2026.
  • Autolus Therapeutics made up 0.02% of Quantum Financial Partners's portfolio in Q2 2026, its #153 holding.
  • 6 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q2 2026.

Based on Quantum Financial Partners's 13F filing for Q2 2026, filed 20 Jul 2026.